Misplaced Pages

Milverine (drug): Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 10:37, 17 December 2024 editMo18ekula (talk | contribs)248 editsmNo edit summary← Previous edit Revision as of 15:48, 18 December 2024 edit undoIdoghor Melody (talk | contribs)Autopatrolled, Event coordinators, Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers32,961 editsm clean upTag: AWBNext edit →
Line 3: Line 3:
| image = Milverine.svg | image = Milverine.svg
| width = 250px | width = 250px
| caption = | caption =


<!-- Clinical data --> <!-- Clinical data -->
Line 21: Line 21:
| class = | class =
| ATC_prefix = | ATC_prefix =
| ATC_suffix = | ATC_suffix =


<!-- Legal status --> <!-- Legal status -->
| legal_status = | legal_status =


<!-- Pharmacokinetic data --> <!-- Pharmacokinetic data -->
Line 34: Line 34:
| elimination_half-life = | elimination_half-life =
| duration_of_action = | duration_of_action =
| excretion = | excretion =


<!-- Identifiers --> <!-- Identifiers -->
Line 58: Line 58:
| StdInChIKey = KMZHYAUKFHLFNY-UHFFFAOYSA-N | StdInChIKey = KMZHYAUKFHLFNY-UHFFFAOYSA-N
}} }}
Milverine is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.<ref> Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID: 5425728.</ref><ref> Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)</ref><ref> Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID: 3770157.</ref> '''Milverine''' is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.<ref>Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.</ref><ref>Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)</ref><ref>Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.</ref>


The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.<ref>Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).</ref> The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.<ref>Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).</ref>
Line 65: Line 65:


==Synthesis== ==Synthesis==
The chemical synthesis of milverine was identified.<ref>Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa). </ref> The chemical synthesis of milverine was identified.<ref>Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).</ref>
] ]
Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively. Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively.

== References == == References ==
{{reflist}} {{reflist}}
{{Urologicals}} {{Urologicals}}
{{Irritable bowel syndrome}} {{Irritable bowel syndrome}}

] ]

Revision as of 15:48, 18 December 2024

Pharmaceutical compound
Milverine
Clinical data
Other namesFenprin, Fenpyramine, Miospasm.
Identifiers
IUPAC name
  • N-(3,3-diphenylpropyl)pyridin-4-amine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H20N2
Molar mass288.394 g·mol
3D model (JSmol)
SMILES
  • C1=CC=C(C=C1)C(CCNC2=CC=NC=C2)C3=CC=CC=C3
InChI
  • InChI=1S/C20H20N2/c1-3-7-17(8-4-1)20(18-9-5-2-6-10-18)13-16-22-19-11-14-21-15-12-19/h1-12,14-15,20H,13,16H2,(H,21,22)
  • Key:KMZHYAUKFHLFNY-UHFFFAOYSA-N

Milverine is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.

The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.

Synthesis

The chemical synthesis of milverine was identified.

Milverine synthesis
Milverine synthesis

Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively.

References

  1. Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.
  2. Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)
  3. Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.
  4. Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).
  5. Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).
Urologicals, including antispasmodics (G04B)
Acidifiers
Urinary antispasmodics
(primarily antimuscarinics)
Other urologicals
Irritable bowel syndrome (IBS)
Management
Related topics
Category: